Directed new share issue in Nuevolution AB (SE) — SEK 110 million

Carnegie acted as financial adviser and sole bookrunner in the directed new share issue of 6,666,667 shares at a subscription price of SEK 16.50 per share. Nuevolution is a leading small molecule drug discovery biotech company founded in 2001, and headquartered in Copenhagen, Denmark. May 2018.